ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer

Primary location

Abramson Cancer Center of the University of Pennsylvania

Philadelphia, Pennsylvania, United States

Contact

Lauren Bayne, PhD